A research intervention in Uganda to test an intervention called Volunteer Support, designed to improve care for people living in the community with severe mental illness

Not Applicable

Completed

• Conditions: Patients with severe mental illness (including psychosis); Mental and Behavioural Disorders

• Registration Number: ISRCTN86689958
• Lead Sponsor: Queen Mary University of London

Brief Summary

2019 Protocol article in https://pubmed.ncbi.nlm.nih.gov/31200671/ (added 11/08/2022)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-03-04
• Study Completion: 2020-06-12
• Last Update Posted: 20 March 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

1. Primary diagnosis of severe mental illness (ICD-10 F20-29, F31, F32)
2. Aged 18-65 years old and over
3. Capacity to provide informed consent assessed by UBACC score of =14
4. Able to communicate in Luganda or English
5. Scores 5 or below on the MANSA scale

Exclusion Criteria

1. Primary diagnosis of substance-use disorder, organic psychosis and/or a neurocognitive disorder
2. Currently an inpatient at the time of recruitment
3. Participating in another study conducted by this or another group

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quality of life, measured using the Manchester Short Assessment of Quality of Life (MANSA) at baseline, 6 and 12 months

Secondary Outcome Measures

Name	Time	Method
<br> 1. Symptoms, measured using the Brief Psychiatric Rating Scale (BPRS) at baseline, 6 and 12 months<br> 2. Objective social situation, measured using the Objective Social Outcomes Index (SIX) at baseline, 6 and 12 months<br> 3. Service use, measured using adapted Client Service Receipt Inventory (CSRI) at baseline, 6 and 12 months<br> 4. Stigma, measured using the Self-Esteem Rating Scale at baseline, 6 months and 12 months<br> 5. Adherence to medication, using the Medication Adherence Rating Scale (MARS) at baseline, 6 and 12 months<br>